Working… Menu

Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01003808
Recruitment Status : Completed
First Posted : October 29, 2009
Last Update Posted : April 17, 2013
Information provided by (Responsible Party):
ImmunoFrontier, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2012
Actual Study Completion Date : December 2012

Publications automatically indexed to this study by Identifier (NCT Number):